Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of EXercise on Quality of Life of Early Breast Cancer Patients on Treatment With Adjuvant Aromatase Inhibitors With or Without CDK4/6 Inhibitors. "The EXAI Study"

NCT07215364 is registered in ClinicalTrials.gov with Spanish Breast Cancer Research Group as lead sponsor.

NCT NCT07215364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of EXercise on Quality of Life of Early Breast Cancer Patients on Treatment With Adjuvant Aromatase Inhibitors With or Without CDK4/6 Inhibitors. "The EXAI Study"
Lead sponsor
Spanish Breast Cancer Research Group
Phase
Not applicable
Overall status
Recruiting
Start date
July 2, 2026
Completion date
March 31, 2029
Enrollment
74 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage breast cancer